Exploiting the 1-(4-fluorobenzyl)piperazine fragment for the development of novel tyrosinase inhibitors as anti-melanogenic agents: Design, synthesis, structural insights and biological profile-Reference-Cited by-同舟云学术

Exploiting the 1-(4-fluorobenzyl)piperazine fragment for the development of novel tyrosinase inhibitors as anti-melanogenic agents: Design, synthesis, structural insights and biological profile

Published:2019-09 Issue: Volume:178 Page:380-389
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Ielo Laura,Deri Batel,Germanò Maria Paola,Vittorio Serena,Mirabile Salvatore,Gitto Rosaria^ORCID,Rapisarda Antonio,Ronsisvalle Simone^ORCID,Floris Sonia,Pazy Yael,Fais Antonella^ORCID,Fishman Ayelet,De Luca Laura^ORCID

Funder

Israel Science Foundation

Israel Academy of Sciences and Humanities

Russell-Berrie Nanotechnology Institute (RBNI)

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference31 articles.

1. Tyrosinase: a comprehensive review of its mechanism;Sanchez-Ferrer;Biochim. Biophys. Acta,1995

2. De novo molecular design of a novel octapeptide that inhibits in vivo melanogenesis and has great transdermal ability;Feng;J. Med. Chem.,2018

3. Enhancement of hepatocarcinogenesis by kojic acid in rat two-stage models after initiation with N-bis(2-hydroxypropyl)nitrosamine or N-diethylnitrosamine;Takizawa;Toxicol. Sci.,2004